Spire Healthcare Group plc (SPI.L) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. SPI.L files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 236.64% | 30.00% | Fail |
| Interest-bearing investments | 3.63% | 30.00% | Pass |
| Non-permissible income | 0.06% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 95.26% | 33.00% | Fail |
| Interest-bearing investments | 1.46% | 33.00% | Pass |
| Non-liquid assets | 95.30% | at least 20.00% | Pass |
| Non-permissible income | 0.06% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 95.26% | 33.33% | Fail |
| Cash + interest-bearing securities | 1.46% | 33.33% | Pass |
| Accounts receivable | 4.70% | 33.33% | Pass |
| Non-permissible income | 0.06% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 95.26% | 33.33% | Fail |
| Cash + interest-bearing securities | 1.46% | 33.33% | Pass |
| Accounts receivable | 4.70% | 50.00% | Pass |
| Non-permissible income | 0.06% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 277.15% | 33.00% | Fail |
| Cash + interest-bearing securities | 4.25% | 33.00% | Pass |
| Accounts receivable | 9.44% | 33.00% | Pass |
| Non-permissible income | 0.06% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 265.73% | 33.00% | Fail |
| Cash + interest-bearing securities | 4.07% | 49.00% | Pass |
| Accounts receivable | 9.05% | 49.00% | Pass |
| Non-permissible income | 0.06% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 265.73% | 33.33% | Fail |
| Cash + interest-bearing securities | 4.07% | 33.33% | Pass |
| Accounts receivable | 13.12% | 49.00% | Pass |
| Non-permissible income | 0.06% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 70.40 | SELL |
| Stochastic %K (14) | 96.88 | SELL |
| CCI (20) | 156.91 | SELL |
| Williams %R (14) | -3.12 | SELL |
| MACD (12,26,9) | 0.69 | BUY |
| ROC (10) | 4.24 | BUY |
| Momentum (10) | 10.00 | BUY |
| EMA (10) | 241.66 | BUY |
| SMA (10) | 240.40 | BUY |
| EMA (20) | 238.37 | BUY |
| SMA (20) | 237.62 | BUY |
| EMA (30) | 235.65 | BUY |
| SMA (30) | 235.93 | BUY |
| EMA (50) | 230.23 | BUY |
| SMA (50) | 229.92 | BUY |
| EMA (100) | 219.64 | BUY |
| SMA (100) | 214.65 | BUY |
| EMA (200) | 211.96 | BUY |
| SMA (200) | 198.09 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Medical Care Facilities
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, digestive and bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. In addition, the company provides eye surgery and treatments, family planning, gastroenterology, general medicine, haematology, hand surgery, hip and knee replacement treatment, and heart and kidney treatments. Further, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal neurosurgery, sports science, urology, vascular surgery, weight loss, and women's health. Additionally, the company provides treatments in the areas of breast enlargement, cataract removal surgery, gastric bypass surgery, and prostate surgery; and offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.
Background via Yahoo Finance — informational, not part of the verdict.
Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.
Based on the filing period ending 2025-12-31, figures in GBP.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.